National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

This is VAERS ID 625919

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 4/14/2016

VAERS ID: 625919
VAERS Form:
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-02-18
Entered:2016-02-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Wheezing

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': 2015370712

Write-up: This is a spontaneous report from a contactable physician via a Pfizer colleague. A female patient of unspecified age received first dose of TRUMENBA on unknown date, at single dose. Medical history and concomitant medications were not reported. The patient became very short of breath with wheezing about 12-15 hours after vaccination. The patient visited an allergist who felt that while this was a side effect to the vaccine and could reoccur (however did not call it an allergic hypersensitivity reaction). Prior to receiving second dose of TRUMENBA, she was pre-medicated with BENADRYL and provided EPIPEN. The same reaction re-occurred. This time the allergist has recommended to not proceed with further immunizations. He did not feel that skin testing or progressive dilution injections would be beneficial because of the delay in the time of the development of symptoms. Events outcome was unknown. Follow-up (24DEC2015): Follow-up attempts are completed. No further information is expected.


Changed on 9/14/2017

VAERS ID: 625919 Before After
VAERS Form:(blank) 1
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-02-18
Entered:2016-02-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 0 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Wheezing

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': 2015370712

Write-up: This is a spontaneous report from a contactable physician via a Pfizer colleague. A female patient of unspecified age received first dose of TRUMENBA on unknown date, at single dose. Medical history and concomitant medications were not reported. The patient became very short of breath with wheezing about 12-15 hours after vaccination. The patient visited an allergist who felt that while this was a side effect to the vaccine and could reoccur (however did not call it an allergic hypersensitivity reaction). Prior to receiving second dose of TRUMENBA, she was pre-medicated with BENADRYL and provided EPIPEN. The same reaction re-occurred. This time the allergist has recommended to not proceed with further immunizations. He did not feel that skin testing or progressive dilution injections would be beneficial because of the delay in the time of the development of symptoms. Events outcome was unknown. Follow-up (24DEC2015): Follow-up attempts are completed. No further information is expected.


Changed on 2/14/2018

VAERS ID: 625919 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-02-18
Entered:2016-02-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Wheezing

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': 2015370712

Write-up: This is a spontaneous report from a contactable physician via a Pfizer colleague. A female patient of unspecified age received first dose of TRUMENBA on unknown date, at single dose. Medical history and concomitant medications were not reported. The patient became very short of breath with wheezing about 12-15 hours after vaccination. The patient visited an allergist who felt that while this was a side effect to the vaccine and could reoccur (however did not call it an allergic hypersensitivity reaction). Prior to receiving second dose of TRUMENBA, she was pre-medicated with BENADRYL and provided EPIPEN. The same reaction re-occurred. This time the allergist has recommended to not proceed with further immunizations. He did not feel that skin testing or progressive dilution injections would be beneficial because of the delay in the time of the development of symptoms. Events outcome was unknown. Follow-up (24DEC2015): Follow-up attempts are completed. No further information is expected.


Changed on 6/14/2018

VAERS ID: 625919 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-02-18
Entered:2016-02-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Wheezing

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': 2015370712

Write-up: This is a spontaneous report from a contactable physician via a Pfizer colleague. A female patient of unspecified age received first dose of TRUMENBA on unknown date, at single dose. Medical history and concomitant medications were not reported. The patient became very short of breath with wheezing about 12-15 hours after vaccination. The patient visited an allergist who felt that while this was a side effect to the vaccine and could reoccur (however did not call it an allergic hypersensitivity reaction). Prior to receiving second dose of TRUMENBA, she was pre-medicated with BENADRYL and provided EPIPEN. The same reaction re-occurred. This time the allergist has recommended to not proceed with further immunizations. He did not feel that skin testing or progressive dilution injections would be beneficial because of the delay in the time of the development of symptoms. Events outcome was unknown. Follow-up (24DEC2015): Follow-up attempts are completed. No further information is expected.


Changed on 8/14/2018

VAERS ID: 625919 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-02-18
Entered:2016-02-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Wheezing

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': 2015370712

Write-up: This is a spontaneous report from a contactable physician via a Pfizer colleague. A female patient of unspecified age received first dose of TRUMENBA on unknown date, at single dose. Medical history and concomitant medications were not reported. The patient became very short of breath with wheezing about 12-15 hours after vaccination. The patient visited an allergist who felt that while this was a side effect to the vaccine and could reoccur (however did not call it an allergic hypersensitivity reaction). Prior to receiving second dose of TRUMENBA, she was pre-medicated with BENADRYL and provided EPIPEN. The same reaction re-occurred. This time the allergist has recommended to not proceed with further immunizations. He did not feel that skin testing or progressive dilution injections would be beneficial because of the delay in the time of the development of symptoms. Events outcome was unknown. Follow-up (24DEC2015): Follow-up attempts are completed. No further information is expected.


Changed on 9/14/2018

VAERS ID: 625919 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-02-18
Entered:2016-02-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Wheezing

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': 2015370712

Write-up: This is a spontaneous report from a contactable physician via a Pfizer colleague. A female patient of unspecified age received first dose of TRUMENBA on unknown date, at single dose. Medical history and concomitant medications were not reported. The patient became very short of breath with wheezing about 12-15 hours after vaccination. The patient visited an allergist who felt that while this was a side effect to the vaccine and could reoccur (however did not call it an allergic hypersensitivity reaction). Prior to receiving second dose of TRUMENBA, she was pre-medicated with BENADRYL and provided EPIPEN. The same reaction re-occurred. This time the allergist has recommended to not proceed with further immunizations. He did not feel that skin testing or progressive dilution injections would be beneficial because of the delay in the time of the development of symptoms. Events outcome was unknown. Follow-up (24DEC2015): Follow-up attempts are completed. No further information is expected.


Changed on 10/14/2018

VAERS ID: 625919 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-02-18
Entered:2016-02-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Wheezing

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': 2015370712

Write-up: This is a spontaneous report from a contactable physician via a Pfizer colleague. A female patient of unspecified age received first dose of TRUMENBA on unknown date, at single dose. Medical history and concomitant medications were not reported. The patient became very short of breath with wheezing about 12-15 hours after vaccination. The patient visited an allergist who felt that while this was a side effect to the vaccine and could reoccur (however did not call it an allergic hypersensitivity reaction). Prior to receiving second dose of TRUMENBA, she was pre-medicated with BENADRYL and provided EPIPEN. The same reaction re-occurred. This time the allergist has recommended to not proceed with further immunizations. He did not feel that skin testing or progressive dilution injections would be beneficial because of the delay in the time of the development of symptoms. Events outcome was unknown. Follow-up (24DEC2015): Follow-up attempts are completed. No further information is expected.


Changed on 12/24/2020

VAERS ID: 625919 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-02-18
Entered:2016-02-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Wheezing

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': 2015370712

Write-up: This is a spontaneous report from a contactable physician via a Pfizer colleague. A female patient of unspecified age received first dose of TRUMENBA on unknown date, at single dose. Medical history and concomitant medications were not reported. The patient became very short of breath with wheezing about 12-15 hours after vaccination. The patient visited an allergist who felt that while this was a side effect to the vaccine and could reoccur (however did not call it an allergic hypersensitivity reaction). Prior to receiving second dose of TRUMENBA, she was pre-medicated with BENADRYL and provided EPIPEN. The same reaction re-occurred. This time the allergist has recommended to not proceed with further immunizations. He did not feel that skin testing or progressive dilution injections would be beneficial because of the delay in the time of the development of symptoms. Events outcome was unknown. Follow-up (24DEC2015): Follow-up attempts are completed. No further information is expected.


Changed on 12/30/2020

VAERS ID: 625919 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-02-18
Entered:2016-02-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Wheezing

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': 2015370712

Write-up: This is a spontaneous report from a contactable physician via a Pfizer colleague. A female patient of unspecified age received first dose of TRUMENBA on unknown date, at single dose. Medical history and concomitant medications were not reported. The patient became very short of breath with wheezing about 12-15 hours after vaccination. The patient visited an allergist who felt that while this was a side effect to the vaccine and could reoccur (however did not call it an allergic hypersensitivity reaction). Prior to receiving second dose of TRUMENBA, she was pre-medicated with BENADRYL and provided EPIPEN. The same reaction re-occurred. This time the allergist has recommended to not proceed with further immunizations. He did not feel that skin testing or progressive dilution injections would be beneficial because of the delay in the time of the development of symptoms. Events outcome was unknown. Follow-up (24DEC2015): Follow-up attempts are completed. No further information is expected.


Changed on 5/7/2021

VAERS ID: 625919 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-02-18
Entered:2016-02-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Wheezing

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': 2015370712

Write-up: This is a spontaneous report from a contactable physician via a Pfizer colleague. A female patient of unspecified age received first dose of TRUMENBA on unknown date, at single dose. Medical history and concomitant medications were not reported. The patient became very short of breath with wheezing about 12-15 hours after vaccination. The patient visited an allergist who felt that while this was a side effect to the vaccine and could reoccur (however did not call it an allergic hypersensitivity reaction). Prior to receiving second dose of TRUMENBA, she was pre-medicated with BENADRYL and provided EPIPEN. The same reaction re-occurred. This time the allergist has recommended to not proceed with further immunizations. He did not feel that skin testing or progressive dilution injections would be beneficial because of the delay in the time of the development of symptoms. Events outcome was unknown. Follow-up (24DEC2015): Follow-up attempts are completed. No further information is expected.


Changed on 5/21/2021

VAERS ID: 625919 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-02-18
Entered:2016-02-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dyspnoea, Wheezing

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': 2015370712

Write-up: This is a spontaneous report from a contactable physician via a Pfizer colleague. A female patient of unspecified age received first dose of TRUMENBA on unknown date, at single dose. Medical history and concomitant medications were not reported. The patient became very short of breath with wheezing about 12-15 hours after vaccination. The patient visited an allergist who felt that while this was a side effect to the vaccine and could reoccur (however did not call it an allergic hypersensitivity reaction). Prior to receiving second dose of TRUMENBA, she was pre-medicated with BENADRYL and provided EPIPEN. The same reaction re-occurred. This time the allergist has recommended to not proceed with further immunizations. He did not feel that skin testing or progressive dilution injections would be beneficial because of the delay in the time of the development of symptoms. Events outcome was unknown. Follow-up (24DEC2015): Follow-up attempts are completed. No further information is expected.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=625919&WAYBACKHISTORY=ON


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166